Bridging the endocrine disruptor assessment of biocidal non-active substances with UK and EU REACH screening and assessment

The guidance broadly corresponds with that developed by ECHA (the European Chemicals Agency) and incorporates GB requirements.

Applies to:
Great Britain, Northern Ireland
Published by:
October 2022
Last updated:
October 2022

Guidance publications


This document proposes a way forward to bridge the assessment of endocrine disrupting (ED) properties of non-active substances (so-called ‘co-formulants’) in biocidal products with the integrated regulatory strategy under Regulation (EC) No 1907/2006 (REACH).

Related content

Explore this topic